Results
1 -
10 of
107Jean-Etienne Fabre and Mark E. Gurney.
Limitations of current therapies to prevent thrombosis: a need for novel strategies, Mol. Biosyst., 2010, 6, 305. Felipe T. Martins, Patrícia V. deLima, Lilian C. Azarias, Polyana J. de Abreu, Person P. Neves, Alexandre O. Legendre, Fabiano M. de Andrade, Guilherme R. de Oliveira, Javier Ellena and Antônio C. Doriguetto.
Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride, CrystEngComm, 2011, 13, 5737. Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs, Allergo Journal International New method for the synthesis of substituted thieno[3,2-b]pyridines and 5H-pyrano[2,3-d]thieno[3,2-b]pyridines derived from them, Russian Chemical Bulletin Synthesis, transformations, and pharmacological properties of thienopyridines (review), Pharmaceutical Chemistry Journal Is There a Need for u201cTriple Therapyu201d? Role of Anticoagulation with Dual Antiplatelet Therapy in Acute Coronary Syndromes (ATLAS Study & TRAP Study), Current Cardiology Reports Chemical Papers.
New Cu(II), Co(II), and Ni(II) complexes with thieno[2,3-b]pyridine and 2-methylthieno[2,3-b]pyridine as ligands: Synthesis and crystal structures, Chemical Papers Pharmacology: Inhibitors of P2Y12, Platelets in Thrombotic and Non-Thrombotic Disorders Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist, Anticoagulants, Antiplatelets, and Thrombolytics Thienopyridines in Stable Coronary Disease, Antithrombotic Drug Therapy in Cardiovascular Disease